Tissue microarray sampling strategy for prostate cancer biomarker analysis

American Journal of Surgical Pathology

Volumn 26, Issue 3, 2002, Pages 312-319

  Rubin, Mark A ^a,b   Dunn, Rodney ^a   Strawderman, Myla ^a   Pienta, Kenneth J ^a  

^a UNIVERSITY OF MICHIGAN COMPREHENSIVE CANCER CENTER   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Biomarkers; Digital image analysis; Expression arrays; Ki 67; Proliferation; Prostate cancer; PSA recurrence; Tissue microarray

Indexed keywords

BIOLOGICAL MARKER; KI 67 ANTIGEN; PROSTATE SPECIFIC ANTIGEN; TUMOR MARKER;

ARTICLE; DIAGNOSTIC VALUE; DNA MICROARRAY; HUMAN; HUMAN TISSUE; MALE; PREOPERATIVE EVALUATION; PROSTATE CANCER; SAMPLING;

BIOLOGICAL MARKERS; HISTOLOGICAL TECHNIQUES; HUMANS; IMMUNOCHEMISTRY; KI-67 ANTIGEN; MALE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROPORTIONAL HAZARDS MODELS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS;

EID: 0036190460     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000478-200203000-00004     Document Type: Article

References (18)

1. Ki-67 expression is a prognostic marker of prostate cancer recurrence after radical prostatectomy
2. Prognostic factors in prostate cancer. College of American Pathologists Consensus statement 1999
3. Ki-67 labeling index: An independent predictor of progression in prostate cancer treated by radical prostatectomy
4. Ki-67 labeling index in core needle biopsies independently predicts tumor-specific survival in prostate cancer
5. Delineation of prognostic biomarkers in prostate cancer
6. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67
7. Classification of prostate carcinoma
8. Relationship of proliferating cell nuclear antigen (PCNA) in prostatic carcinomas to various clinical parameters
9. Validation of tissue microarrays for immunohistochemical profiling of cancer specimens using the example of human fibroblastic tumors
10. The prognostic significance of proliferation-associated nucleolar protein p120 expression in prostate adenocarcinoma: A comparison with cyclins A and B1, Ki-67, proliferating cell nuclear antigen, and p34cdc2
11. Bcl-2 oncoprotein positivity and high MIB-1 (Ki-67) proliferative rate are independent predictive markers for recurrence in prostate carcinoma
12. Tissue microarrays for high-throughput molecular profiling of tumor specimens
13. Neuroendocrine expression in metastatic prostate cancer: Evaluation of high throughput tissue microarrays to detect heterogeneous protein expression
14. Expression of nuclear antigen Ki-67 in prostate cancer needle biopsy and radical prostatectomy specimens
15. Microarrays of bladder cancer tissue are highly representative of proliferation index and histologic grade
16. Tissue microarray assessment of prostate cancer tumor proliferation in African-American and white men
17. Assessment of the biologic markers p53, Ki-67, and apoptotic index as predictive indicators of prostate carcinoma recurrence after surgery
18. Cancer prognostics: Past, present and p27